Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

(Unaudited)

December 31,

2007 2006

ASSETS

Current assets:

Cash and cash equivalents $102,945 $78,948

Restricted cash 1,939 275

Accounts receivable, net 5,389 5,380

Inventories 2,213 3,026

Prepaid expenses 3,224 3,447

Other current assets 381 487

Total current assets 116,091 91,563

Property and equipment, net 3,941 2,107

Intangible assets, net 36,040 69,140

Goodwill 38,213 38,213

Long-term restricted cash and investments 12,000 12,000

Other long-term assets 1,269 1,548

Total assets $207,554 $214,571

LIABILITIES, CONVERTIBLE PREFERRED

STOCK, AND STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities:

Line of credit $3,459 $2,191

Accounts payable 2,856 5,443

Accrued liabilities 29,047 12,943

Deferred revenue 1,494 1,422

Preferred stock warrant liability - 8,521

Total current liabilities 36,856 30,520

Deferred rent and other non-current

liabilities - 534

Non
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... DIEGO , May 20, 2015  Cypher ... announced a collaboration with Celgene Corporation to apply ... genomic biomarkers that associate with patient response to ... is intended to help accelerate patient access to ... efficiencies in clinical research and development and potentially ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... addition of the "Bone Morphogenetic Proteins Market ... Trauma, Reconstructive and Oral - Maxillofacial) - Global ... 2014 - 2022" report to their offering. ... is studied based on the types of recombinant ...
(Date:5/20/2015)... MA (PRWEB) May 20, 2015 ... transporter assay services for Drug-Drug Interactions (DDI), Metabolism ... Pharma, a world leader in assessing impact of ... Systems Pharmacology supported by biosimulation, announced today that ... agreement allows both companies to expand their product ...
(Date:5/20/2015)... 20, 2015  HOSTING, the leading provider of ... is an official partner of the College ... Members Services Program. This unique collaboration leverages ... services and best practices derived from the ... service providers, enabling member healthcare organizations to ...
Breaking Biology Technology:Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Global Bone Morphogenetic Proteins Market Industry Analysis 2014 - 2022 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3HOSTING Named Partner of the CHIME Cooperative Member Services Program 2HOSTING Named Partner of the CHIME Cooperative Member Services Program 3
... - Researchers are developing a new type of computer ... memory and use far less power than flash memory ... "ferroelectric" polymer, a material that switches polarity when electric ... ferroelectric transistor. "It,s in a very nascent stage," ...
... Renmatix , the leading producer of ... company,s commercial approach to producing sugars more cheaply ... industrial sugars, the foundation of the emerging bioindustrial ... fuels and chemicals to cost-effective biobased alternatives. ...
... Verenium Corporation (Nasdaq: VRNM ), a leading ... announced that it retired its remaining secured 9% Notes ... principal amount of unsecured 5.5% Notes outstanding. ... principal amount of its 9% Notes, the Company paid ...
Cached Biology Technology:New 'FeTRAM' is promising computer memory technology 2Renmatix Reveals Supercritical Hydrolysis as Lowest-Cost Pathway to Cellulosic Sugar 2Renmatix Reveals Supercritical Hydrolysis as Lowest-Cost Pathway to Cellulosic Sugar 3Verenium Announces Debt Repurchase 2Verenium Announces Debt Repurchase 3
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/8/2015)... SAN JOSE, Calif. , May 8, 2015 ... human interface solutions, today announced that members of the executive ... J.P. Morgan 43rd Annual Technology, Media and Telecom Conference ... Westin Waterfront Hotel in Boston, MA ... Date: May 27, 2015 Time: 2:45pm ET Location: The New ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... better way to predict earthquakes and avalanches may soon ... at NJIT. Using mathematical modeling, researchers are ... "Computational Homology, Jamming and Force Chains ... Foundation grant has been awarded to Louis Kondic, associate ...
... taskswould have smiled at one of leptin,s mechanisms for curbing ... enlists the sympathetic nervous system to prevent bone-making cells from ... The study will appear online December 22, 2008 ( ... of The Journal of Cell Biology ( JCB ...
... Clive Svendsen,s lab dishes, he couldn,t have been more ... lost in patients with the devastating neurological disease spinal ... stem cell biologist had recreated the hallmarks of a ... from a patient. By allowing scientists the unparalleled ...
Cached Biology News:To improve forecasting earthquakes, NJIT mathematician studies grains 2Leptin's long-distance call to the pancreas 2Patient-derived induced stem cells retain disease traits 2Patient-derived induced stem cells retain disease traits 3
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
... CLS number is a new product ... product number. If showing no availability ... Sigma-Aldrich number (Z71,517-4) or contact customer ... polystyrene (expanded surface, easy grip) ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
Biology Products: